glp-1 agonists reduce inflammation receptor and next-generation metabolic hormone therapies in chronic kidney disease You've heard about GLP-1s for
Description
Theyre serious medications with strict usage requirements that are intended for chronic weight management." Researchers have also raised concerns that GLP-1 receptor agonists could be linked to more serious illnesses
Glucagon-like peptide-1 or GLP-1 is native to the body and is released from the small intestine after a meal ingestion
This significantly reduces the long-term risk of heart attack and stroke
GLP-1 also significantly slows gastric emptying
Download Summary Sheet Here
They were found to have significant HbA1c, and weight reduction compared to placebo in patients with diabetes and obesity respectively
